caus
novel
coronaviru
emerg
wuhan
hubei
provinc
sinc
decemb
caus
rapid
outbreak
throughout
china
global
citi
outsid
hubei
also
face
great
challeng
requir
implement
effect
feasibl
strategi
precis
diagnos
novel
coronaviru
pneumonia
ncp
describ
multicent
prospect
studi
diagnost
strategi
suspect
ncp
patient
januari
nd
februari
th
eastern
china
citi
nasopharyng
swab
collect
patient
epidemiolog
characterist
clinic
symptom
laboratori
assess
comput
tomograph
ct
scan
obtain
pathogen
screen
perform
includ
rtpcr
multiplex
pcr
rapid
flu
antigen
test
mng
enrol
suspect
ncp
patient
among
laboratoryconfirm
fourteen
patient
posit
first
second
rtpcr
test
respect
ncp
patient
posit
mng
chest
ct
imag
symptom
earli
stage
ncp
patient
similar
viral
pneumonia
patient
identifi
coinfect
ncp
case
includ
regular
respiratori
viru
fungi
bacteria
synchron
genom
analysi
show
case
mutat
viru
genom
case
one
singl
mutat
n
gene
studi
discov
combin
chest
ct
rtpcr
multiplex
pcr
recommend
region
outsid
hubei
provinc
coinfect
pathogen
exist
acknowledg
repeat
sampl
chang
specimen
type
metagenom
sequenc
could
facilit
critic
clinic
case
sinc
decemb
cluster
unexplain
pneumonia
emerg
wuhan
china
rapidli
spread
throughout
china
global
earli
januari
chines
health
author
announc
caus
agent
isol
novel
coronaviru
whole
genom
publish
viru
initi
name
novel
coronaviru
renam
th
feb
februari
th
total
report
confirm
corona
viru
diseas
covid
case
reach
within
china
case
countri
global
increas
number
case
widen
geograph
spread
rais
concern
intern
apart
transmiss
pattern
characterist
viru
one
reason
initi
rapid
growth
infectedpati
number
insuffici
abil
rapidli
detect
huge
amount
suspect
case
especi
citi
million
popul
could
led
untim
discov
quarantin
patient
infect
aggrav
epidem
outsid
hubei
provinc
sporad
cluster
case
continu
report
within
china
provinc
municip
confirm
around
case
countri
includ
usa
south
korea
japan
etc
also
sporad
cluster
report
current
epidem
control
outsid
hubei
provinc
countri
enter
critic
stage
control
elimin
epidem
still
main
task
till
thu
prevent
singl
spark
start
prairi
fire
observ
wuhan
critic
therefor
optim
diagnost
strategi
urgent
essenti
futur
global
control
prevent
chest
computer
tomographi
ct
import
method
identifi
lung
lesion
studi
involv
patient
shown
around
laboratoryconfirm
patient
novel
coronaviru
pneumonia
ncp
admiss
usual
exhibit
typic
radiolog
find
groundglass
opac
bilater
patchi
shadow
howev
specif
chest
ct
rel
low
current
golden
standard
ncp
diagnosi
posit
result
realtim
reversetranscriptas
polymerasechainreact
rtpcr
assay
metagenom
sequenc
respiratori
specimen
includ
nasal
pharyng
swab
specimen
sputum
bronchoalveolar
lavag
fluid
importantli
rtpcr
requir
perform
least
twice
suspect
case
admiss
day
day
achiev
two
neg
result
order
patient
releas
howev
recent
physician
around
china
report
case
ncp
even
continu
neg
rtpcr
result
nasopharyng
throat
swab
specimen
final
laboratoryconfirm
accord
recent
diagnosi
treatment
guidelin
new
coronaviru
pneumonia
fifth
edit
china
ct
imag
result
use
clinic
diagnost
criteria
ncp
strictli
limit
hubei
provinc
phenomenon
rais
nation
concern
discuss
improv
diagnost
strategi
novel
coronaviru
pneumonia
ncp
current
circumst
consid
high
incid
viral
lung
diseas
season
cold
winter
citi
outsid
hubei
provinc
also
face
great
challeng
implement
effect
feasibl
strategi
precis
diagnos
ncp
patient
miss
diagnos
ncp
patient
lead
exposur
risk
commun
health
care
worker
overdiagnos
suspect
patient
mean
occup
medic
resourc
increas
crossinfect
pneumonia
patient
usual
arrang
ward
ncp
patient
lead
unnecessari
panic
gradual
deplet
medic
resourc
articl
pilot
studi
aim
detail
describ
pathogen
suspect
ncp
patient
easternchina
region
compar
efficaci
differ
diagnost
approach
ncp
diagnosi
provid
evid
futur
strateg
diagnosi
region
outsid
hubei
provinc
describ
multicent
prospect
studi
diagnosi
suspect
pneumonia
ncp
januari
nd
februari
th
eastern
china
citi
case
diagnos
base
interim
guidanc
accord
chines
guidelin
suspect
ncp
case
identifi
pneumonia
chest
ct
one
two
follow
criteria
met
fever
respiratori
symptom
normal
decreas
white
blood
cell
count
decreas
lymphocyt
count
travel
histori
contact
patient
fever
respiratori
symptom
hubei
provinc
confirm
case
within
week
confirm
case
ncp
defin
posit
nucleotid
result
either
metagenom
sequenc
rtpcr
assay
nasopharyng
swab
specimen
sever
case
defin
one
follow
respiratori
distress
respiratori
rate
per
minut
puls
oxygen
satur
room
air
oxygen
index
oral
consent
obtain
patient
studi
approv
ethic
review
committe
huashan
hospit
affili
fudan
univers
epidemiolog
characterist
includ
recent
exposur
histori
clinic
symptom
sign
laboratori
assess
ct
scan
obtain
data
collect
form
electron
medic
record
laboratori
assess
consist
complet
blood
count
liver
function
creactiv
protein
direct
antigen
flu
ab
test
sampl
collect
laboratori
test
nasopharyng
swab
sampl
collect
extract
total
rna
includ
suspect
patient
admiss
day
fever
clinic
day
collect
nasopharyng
swab
place
collect
tube
ml
viru
transport
solut
copan
utm
viral
transport
usa
onemillilit
sampl
sent
rtpcr
key
laboratori
pathogen
microorgan
huashan
hospit
jingan
district
center
diseas
prevent
control
first
rtpcr
result
neg
second
nasopharyng
sampl
observ
patient
would
collect
day
rtpcr
test
meantim
utm
sent
fast
simultan
multiplex
realtim
revers
transcript
nucleic
acid
amplif
assay
qualit
detect
identif
multipl
respiratori
viral
bacteri
nucleic
acid
nasopharyng
swab
use
qiagen
resplex
ii
kit
includ
total
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
germani
sent
metagenom
sequenc
metagenom
sequenc
rna
reversetranscrib
cdna
sequenc
librari
prepar
qualifi
librari
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
sequenc
illumina
nextseq
use
singleend
mode
lowqual
read
read
deriv
human
genom
sequenc
remov
de
novo
assembl
done
use
spade
sequenc
read
align
curat
databas
taxonom
classif
pathogen
identif
describ
previous
statist
analysi
categor
variabl
describ
frequenc
rate
continu
variabl
describ
use
median
interquartil
rang
iqr
valu
mean
continu
variabl
compar
use
independ
group
test
data
normal
distribut
otherwis
mannwhitney
test
use
proport
categor
variabl
compar
use
test
although
fisher
exact
test
use
data
limit
statist
analys
perform
use
spss
statist
packag
social
scienc
version
softwar
spss
inc
unadjust
comparison
less
consid
statist
signific
thirti
genom
coron
virus
download
ncbi
wuhan
genom
releas
china
gisaid
http
wwwgisaidorg
phylogenet
analysi
phylogenet
tree
construct
base
n
gene
sequenc
mean
maximumlikelihood
method
total
sampl
sequenc
coverag
includ
analysi
align
multipl
sequenc
perform
clustalw
program
mega
softwar
version
role
fund
sourc
funder
studi
role
studi
design
data
collect
data
analysi
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
studi
enrol
patient
suspect
ncp
twenti
patient
final
laboratoryconfirm
ncp
among
patient
posit
first
admiss
rtpcr
patient
turn
posit
second
test
first
neg
result
three
patient
diagnos
mng
rtpcr
report
neg
figur
abnorm
chest
ct
imag
detect
among
patient
accord
ct
scan
ncp
patient
show
bilater
pneumonia
patient
show
unilater
pneumonia
nonncp
patient
show
unilater
bilater
patchi
shadow
tfour
nonncp
ncp
patient
show
groundglass
opac
respect
ct
imag
patient
subsegment
area
consolid
studi
chest
ct
imag
earli
stage
ncp
patient
show
unilater
bilater
ground
glass
opac
similar
nonncp
imag
patient
rsv
mycoplasma
parainfluenza
viru
find
progress
stage
chest
ct
imag
bilater
multipl
lobular
subsegment
area
consolid
figur
accord
qiastat
metagenom
sequenc
result
found
coinfect
case
among
ncp
case
includ
virus
influenza
ab
rhinoenteroviru
respiratori
syncyti
viral
etc
atyp
pathogen
fungi
bacteria
synchron
figur
among
laboratoryconfirm
nonncp
patient
qiastat
metagenom
sequenc
report
posit
patient
respect
pathogen
distribut
nonncp
case
shown
figur
phylogenet
analysi
perform
investig
genet
relationship
pathogen
coronaviru
well
divers
among
strain
consist
previou
report
identifi
new
speci
similar
sarscov
strain
sequenc
case
highli
conserv
origin
wuhan
strain
genet
variat
analyz
case
suffici
coverag
depth
n
gene
among
one
singl
nucleotid
mutat
identifi
two
sampl
result
nonsynonym
chang
n
gene
suggest
rel
low
level
genet
polymorph
case
figur
studi
enrol
suspect
case
case
final
laboratoryconfirm
ncp
among
patient
also
coinfect
pathogen
caus
pathogen
detect
multiplex
respiratori
pcr
panel
mng
nonncp
group
pathogen
rsv
parainfluenza
viru
may
share
similar
radiolog
pattern
ncp
group
includ
bilater
multipl
lobular
groundglass
opac
consolid
indic
region
eastern
china
pathogen
still
compos
approxim
suspect
unexplain
pneumonia
therefor
chest
ct
alon
could
use
diagnost
criterion
infect
combin
chest
ct
diagnost
method
essenti
decreas
chanc
misdiagnosi
area
outsid
hubei
provinc
previou
articl
research
found
sever
icu
patient
coinfect
bacteria
fungi
probabl
occur
secondari
sever
ard
larg
dose
long
time
glucocorticoid
therapi
common
pathogen
includ
baumannii
k
pneumonia
flavu
c
glabrata
c
albican
howev
studi
found
coinfect
viru
case
common
bacteri
fungi
includ
influenza
rhinoenteroviru
respiratori
syncyti
viral
etc
suggest
viru
coinfect
may
common
phenomena
winter
pneumonia
case
thu
posit
pathogen
result
especi
viru
atyp
pathogen
type
common
pathogen
detect
unexplain
pneumonia
exclus
criteria
unexplain
pneumonia
diagnosi
laboratoryconfirm
ncp
case
nasopharyng
swab
specimen
neg
rtpcr
first
time
turn
posit
second
time
anoth
specimen
test
neg
time
final
diagnos
metagenom
sequenc
result
suggest
current
rtpcr
inde
least
fals
neg
rate
howev
mng
posit
rtpcr
neg
sampl
rel
low
sequenc
read
suggest
low
viral
load
upper
respiratori
tract
possibl
low
contagi
risk
patient
reason
lie
behind
phenomenon
may
due
sever
caus
one
influenc
factor
sampl
techniqu
found
high
copi
ncp
viru
deep
nasopharyng
swab
sampl
patient
whose
first
nasopharyng
swab
collect
one
day
anoth
physician
neg
suggest
standard
sampl
strictli
accord
protocol
may
increas
sensit
specimen
also
case
publish
tend
use
nasopharyng
swab
specimen
nucleic
acid
test
studi
reveal
ncp
patient
mild
pneumonia
viral
load
mng
sequenc
read
nasopharyng
swab
specimen
could
high
copiesul
patient
seen
supplement
highest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
among
patient
meanwhil
patient
sever
symptom
rel
low
viru
load
detect
form
nasal
swab
sampl
exampl
patient
admit
hospit
sever
pneumonia
oxygen
satur
howev
viral
load
sampl
mng
detect
uniqu
read
rel
lower
ncp
patient
supplement
possibl
explan
could
ncp
patient
lesion
tend
locat
lower
respiratori
tract
caus
rtpcr
posit
upper
respiratori
tract
sampl
reduc
factor
rna
extract
efficaci
qualiti
kit
potenti
interfer
multipl
primer
could
also
affect
detect
rtpcr
assay
possibl
mutat
primer
probe
region
could
lead
falseneg
detect
albeit
region
reserv
although
wg
data
nt
found
mutat
primer
region
patient
howev
risk
alway
exit
primer
design
also
partial
reli
chosen
gene
gene
specif
gene
effect
distinguish
coronavirus
includ
sar
sar
like
virus
use
design
specif
pcr
detect
primer
n
e
gene
may
form
crossreact
coronavirus
metagenom
sequenc
method
initi
identifi
despit
longer
turnaround
time
higher
cost
mng
demonstr
satisfi
level
sensit
compar
pcr
assay
studi
moreov
natur
unbias
sequenc
offer
higher
toler
genet
drift
target
pathogen
wherea
certain
chang
sequenc
result
critic
impact
assay
effici
along
target
assay
mng
serv
indispens
tool
sensit
close
monitor
molecular
evolut
genet
inform
offer
valuabl
insight
public
health
manag
also
contenti
optim
diagnost
assay
therefor
epidem
current
enter
critic
stage
within
china
global
accord
result
studi
follow
improv
molecular
diagnosi
recommend
optim
diagnost
flow
diagram
figur
first
repeat
sampl
could
increas
posit
especi
clinic
situat
epidemiolog
histori
clinic
manifest
highli
indic
ncp
third
fourth
sampl
may
help
resourc
avail
second
studi
show
mng
show
reliabl
stabl
detect
abil
ncp
diagnosi
may
facilit
solv
diagnost
difficulti
import
critic
clinic
case
low
posit
rtpcr
result
order
circumv
possibl
mutat
rtpcr
primer
region
gene
target
recommend
amplifi
design
rtpcr
assay
whole
genom
sequenc
wg
method
overcom
mutat
problem
caus
falseneg
result
rtpcr
therefor
use
method
enrol
patient
continu
use
mutat
surveil
lastli
lower
respiratori
tract
specimen
might
provid
higher
posit
due
higher
viral
load
may
detect
therefor
physician
might
collect
sampl
bronchoscopi
trachea
cannula
medic
protect
futur
rapid
serolog
test
antigen
antibodi
target
molecular
assay
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
eg
pcror
crisprbas
one
current
develop
success
valid
method
could
use
combin
diagnost
method
assist
clinic
practic
studi
limit
rel
small
sampl
size
studi
need
valid
find
also
sputum
lower
respiratori
tract
serum
fecal
sampl
collect
laboratoryconfirm
patient
studi
collect
sampl
larger
cohort
would
help
improv
diagnost
strategi
studi
discov
low
epidem
region
outsid
hubei
provinc
easternchina
region
current
reliabl
first
approach
unexplain
pneumonia
combin
chest
ct
rtpcr
multiplex
pcr
rapid
influenza
antigen
test
rtpcr
could
also
use
substitut
chest
ct
alon
could
precis
diagnos
due
similar
radiolog
present
coinfect
pathogen
exist
acknowledg
differ
sampl
approach
may
also
affect
result
therefor
highli
suspect
case
two
neg
rtpcr
result
repeat
sampl
chang
sampl
type
could
increas
posit
rate
metagenom
sequenc
could
facilit
critic
clinic
case
monitor
molecular
evolut
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
test
elisa
crispr
lamp
etc
valid
detect
test
may
also
use
firststep
diagnosi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
